首页> 美国卫生研究院文献>Molecules >Synthesis of Potent Inhibitors of β-Ketoacyl-Acyl Carrier Protein Synthase III as Potential Antimicrobial Agents
【2h】

Synthesis of Potent Inhibitors of β-Ketoacyl-Acyl Carrier Protein Synthase III as Potential Antimicrobial Agents

机译:β-酮酰基-酰基载体蛋白合酶III潜在抑制剂的合成

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Mycobacterium tuberculosis FabH, an essential enzyme in the mycolic acid biosynthetic pathway, is an attractive target for novel anti-tubercolosis agents. Structure-based design and synthesis of 1-(4-carboxybutyl)-4-(4-(substituted benzyloxy)phenyl)-1H-pyrrole-2-carboxylic acid derivatives >7a–h, a subset of eight potential FabH inhibitors, is described in this paper. The Vilsmeier-Haack reaction was employed as a key step. The structures of all the newly synthesized compounds were identified by IR, 1H-NMR, 13C-NMR, ESI-MS and HRMS. The alamarBlue™ microassay was employed to evaluate the compounds >7a–h against Mycobacterium tuberculosis H37Rv. The results demonstrate that the compound >7d possesses good in vitro antimycobacterial activity against Mycobacterium tuberculosis H37Rv (Minimum Inhibitory Concentration value [MIC], 12.5 µg/mL).These compounds may prove useful in the discovery and development of new anti-tuberculosis drugs.
机译:结核分枝杆菌FabH是霉菌酸生物合成途径中的必需酶,是新型抗结核病药物的诱人靶标。 1-(4-羧丁基)-4-(4-(取代苄氧基)苯基)-1H-吡咯-2-羧酸衍生物> 7a–h 的结构设计与合成本文介绍了八种潜在的FabH抑制剂。 Vilsmeier-Haack反应被用作关键步骤。通过IR, 1 H-NMR, 13 C-NMR,ESI-MS和HRMS鉴定所有新合成的化合物的结构。 alamarBlue™微量分析用于评估化合物> 7a–h 对结核分枝杆菌H37Rv的抵抗力。结果表明,该化合物> 7d 对结核分枝杆菌H37Rv具有良好的体外抗分枝杆菌活性(最小抑菌浓度值[MIC],12.5 µg / mL)。这些化合物可能被证明可用于发现和开发新的抗结核药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号